| Literature DB >> 32635782 |
Mohadeseh Haji Abdolvahab1, Behrad Darvishi1, Mohammad Zarei2,3, Keivan Majidzadeh-A1, Leila Farahmand1.
Abstract
Interferons (IFNs) are a group of signaling cytokines, secreted by host cells to induce protection against various disorders. IFNs can directly impact on tumor cells or indirectly induce the immune system to protect host cells. The expression levels of IFNs and its functions of are excellently modulated in a way to protect host cells from probable toxicities caused by extreme responses. The efficacy of anticancer therapies is correlated to IFNs signaling. Although IFN signaling is involved in induction of antitumor responses, chronic stimulation of the IFN signaling pathway can induce resistance to various antineoplasm therapies. Hence, IFNs are expressed by both cancer and immune cells, and modulate their biological function. Understanding this mechanism of action might be a key target of combination therapies.Entities:
Keywords: cancer; cancer therapy; immunotherapy; interferons; tumor
Year: 2020 PMID: 32635782 DOI: 10.2217/imt-2019-0217
Source DB: PubMed Journal: Immunotherapy ISSN: 1750-743X Impact factor: 4.196